Live news related to ARGENX SE stock (NL0010832176): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Argenx SE's stock fell by 6.69% midday on December 15, following the halt of the Phase 3 UplighTED study for the subcutaneous efgartigimod in thyroid …
